New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Carotech to reveal Tocomin SupraBio studies at SSW

Company will share the latest human clinical trials of its self-affirmed-GRAS, patented and bioenhanced natural full spectrum palm tocotrienol complex.

Carotech, the largest and only GMP-certified palm tocotrienol complex producer in the world will exhibit at the SupplySide West Expo at Las Vegas from November 7 to 8, 2012.

The SupplySide West show is one of the most attended events focusing on healthy ingredients and products. It is the gathering place for manufacturers, researchers, marketers, as well as business decision makers for the nutraceutical and dietary supplement industry.

Carotech, a regular exhibitor at SupplySide West, will continue to share with customers and visitors the latest human clinical trials of its self-affirmed GRAS, patented and bioenhanced natural full spectrum palm tocotrienol complex (Tocomin SupraBio®).

A recent published human clinical study in the Journal of Nutrition shows that tocotrienols from Tocomin SupraBio were well absorbed and significantly distributed to vital human tissues and organs, in the presence of alpha-tocopherol. This is the first ever actual tissue distribution study of tocotrienols on humans and thereby unequivocally dispelling claims that tocopherol inhibits the absorption of tocotrienols.

In addition, researchers from the University Science of Malaysia have recently completed a  randomized, double-blind, placebo-controlled clinical trial in human volunteers who have white matter lesions, with the aim to compare lesion volumes before and after supplementation of either Tocomin SupraBio or placebo. The researchers used Magnetic Resonance Imaging (MRI) to detect the occurrence and volume of white matter lesions. White matter lesions are subclinical areas of brain damage strongly associated with established cardiovascular risk factors and is an independent risk factor for stroke. This clinical study, the largest ever trial specifically on tocotrienols, has been submitted and pending publication in a peer-reviewed journal. The results are encouraging with significant positive outcome.

“More recently, researchers at the Ohio State University Medical Center have announced the commencement of another large scale human clinical trial on neuroprotection,” says Mr. Bryan See, regional product manager, Carotech Inc.

For more information or the latest research on Tocomin SupraBio, as well as application strategies, visit Carotech Inc. at SupplySide West, Booth no. 18033.

About Carotech
Carotech Ltd, incorporated in 1990, is the first and largest producer of natural full spectrum tocotrienol/tocopherol complex (Tocomin® & Tocomin SupraBio®), natural mixed carotene complex (Caromin®) and phytosterol complex (Stelessterol™) in the world via its patented technology.

Carotech is the only GMP-Certified tocotrienol producer in the world. Its laboratory is accredited with ISO/ISE 17025 accreditation.

Tocomin SupraBio® is a patented (US Patent No. 6,596,306) self emulsifying palm tocotrienol complex that ensures optimal oral absorption of each individual tocotrienols.

Carotech is an investment of Hovid Ltd, one of the largest GMP-certified pharmaceutical companies in Malaysia.

Carotech manufactures these products under the tradenames: Tocomin®, Tocomin SupraBio®, Caromin® and Stelessterol™.

Carotech’s branded ingredients are 100% Non-GMO, Kosher and Halal certified.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.